Serdemetan (JNJ-26854165)

Serdemetan (JNJ-26854165) acts as a HDM2 ubiquitin ligase antagonist and also induces early apoptosis in p53 wild-type cells, inhibits cellular proliferation followed by delayed apoptosis in the absence of functional p53. Phase 1.
Supplier Selleck Chemicals
Product # S1172
Sku # S1172-25mg
Pricing 25mg, $370.00
Feedback